Instituto de Cardiologia de Corrientes Juana F. Cabral | Corrientes, Argentina

Corrientes 3400

0 studies enrolling now · 3 studies all time

What they study most

Atrial Fibrillation, Chronic Heart Failure With Reduced Ejection Fraction, Heart Failure, Prevention of Stroke or Systemic Embolism

Studies at this site

• A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction — Completed
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early